African Union says Russia offers 300 mln doses of Sputnik V vaccine
The African Union's vaccine task team said on Friday that Russia had offered it 300 million doses of its Sputnik V COVID-19 vaccine and that the offer included a financing package for countries wanting to secure the shots. It said in a statement that the Sputnik V vaccine would be available for a period of 12 months starting May 2021.
Reuters | Johannesburg | Updated: 19-02-2021 15:30 IST | Created: 19-02-2021 15:14 IST
The African Union's vaccine task team said on Friday that Russia had offered it 300 million doses of its Sputnik V COVID-19 vaccine and that the offer included a financing package for countries wanting to secure the shots.
It said in a statement that the Sputnik V vaccine would be available for a period of 12 months starting May 2021. Only a handful countries in Africa have started to roll out vaccination programmes, lagging some wealthier nations that are well into their immunisation campaigns.
"We are grateful to receive the Sputnik V vaccines from the Russian Federation and tremendously proud to be able to offer them ... for our AU Member States," John Nkengasong, director of the AU's disease control body, was quoted as saying in the statement. "Bilateral and private sector partnerships such as these are critical in our efforts to bring the COVID-19 pandemic to an end," Nkengasong added.
The AU previously said it had secured 270 million doses of vaccine from AstraZeneca, Pfizer and Johnson & Johnson for delivery this year. On Friday, the vaccine team said all 270 million doses had been "taken up by the first allocation phase deadline".
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Canada to pause AstraZeneca COVID-19 vaccine use for those under 55, require new risk analysis
BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses
Berlin state hospitals halt AstraZeneca vaccinations of women under 55
Kenya joins Canada-Africa Chamber of Business
Covaxin, Covishield effective against UK, Brazilian variant of SARS-CoV-2. Work against South African variant going on: Govt.